Kampavata is not described as an independent Vyadhi in the Brihattrayee and Laghutrayee; however, Madhavakara describes a comparable condition as Vepathu. Clinically, Kampavata correlates with tremor-dominant Parkinson’s disease, a prevalent movement disorder. Kampa, the cardinal feature, manifests as Sarvanga or Shiro Kampa due to Prakopa of the Chala Guna of vitiated Vata Dosha. Conventional management mainly provides symptomatic relief and is associated with long-term drug dependence and adverse effects such as nausea, hallucinations, dry mouth, constipation, and compulsive behavior. Ayurveda emphasizes correction of underlying Vata Dushti through Panchakarma and Shamana Chikitsa. This case study evaluates Vatahara Panchakarma procedures followed by internal medications possessing Brimhana, Rasayana, and neuroprotective properties. Clinical outcomes were assessed based on motor symptoms, daily functional performance, and quality of life. The intervention resulted in notable symptomatic improvement, better functional stability, and absence of adverse effects. These findings suggest that Panchakarma-supported Shamana Chikitsa may be a safe and effective complementary approach in the management of Kampavata (Parkinson’s disease). Further controlled clinical studies are required for validation.
2Vd. Rahul Surendra Kathawate *1Vd. Mayuri Anil Sonkamble (Sun,) studied this question.